Oncology
Showing 251 to 293 of 293 entries
| Category | Product Name | ABC # | Size | NDC # | Manufacturer | |
|---|---|---|---|---|---|---|
| Oncology | Venclexta® | 10246882 | Starter Pack | 00074-0579-28 | Abbvie | |
| Oncology | Venclexta® | 10247465 | 14 × 10 mg tab wallet | 00074-0561-14 | Abbvie | |
| Oncology | Venclexta® | 10245440 | 7 × 50 mg tab wallet | 00074-0566-07 | Abbvie | |
| Oncology | Venclexta® | 10245947 | 2 × 10 mg tab UD | 00074-0561-11 | Abbvie | |
| Oncology | Venclexta® | 10244483 | 1 × 100 mg tab UD | 00074-0576-11 | Abbvie | |
| Oncology | Venclexta® | 10248933 | 1 × 50 mg tab UD | 00074-0566-11 | Abbvie | |
| Oncology | Vidaza® | 10247065 | 100 mg | 59572-0102-01 | Celgene Corporation | |
| Oncology | Vitrakvi® | 10245813 | 25 mg cap 60 | 71777-0390-01 | Bayer | |
| Oncology | Vitrakvi® | 10248913 | 100 mg cap 60 | 50419-0391-01 | Bayer | |
| Oncology | Vitrakvi® | 10251969 | 20 mg/mL 100 mL SOL (Pediatric formulation) | 50419-0392-01 | Bayer | |
| Oncology | Vizimpro® | 10245672 | 15 mg tab 30 | 00069-0197-30 | Pfizer | |
| Oncology | Vizimpro® | 10244780 | 30 mg tab 30 | 00069-1198-30 | Pfizer | |
| Oncology | Vizimpro® | 10248025 | 45 mg tab 30 | 00069-2299-30 | Pfizer | |
| Oncology | Vonjo™ | 10265496 | 100 mg/120 caps | 72482-0100-12 | CTI Biopharma | |
| Oncology | Votrient® | 10242474 | 200 mg/120 tabs | 00078-0670-66 | Novartis | |
| Oncology | Vyxeos® | 10245954 | 44 mg/100 mg 2 pk | 68727-0745-02 | Jazz Pharmaceuticals | |
| Oncology | Vyxeos® | 10248967 | 44 mg/100 mg 5 pk | 68727-0745-05 | Jazz Pharmaceuticals | |
| Oncology | Xalkori® | 10245467 | 200 mg cap 60 | 00069-8141-20 | Pfizer | |
| Oncology | Xalkori® | 10247459 | 250 mg cap 60 | 00069-8140-20 | Pfizer | |
| NEW | Oncology | Xalkori® | 10284753 | 150 MG CAP 60 DS | 00069-1500-60 | Pfizer |
| NEW | Oncology | Xalkori® | 10284606 | 20 MG CAP 60 DS | 00069-0251-60 | Pfizer |
| NEW | Oncology | Xalkori® | 10284752 | 50 MG CAP 60 DS | 00069-0507-60 | Pfizer |
| Oncology | Xerava™ | 10247104 | 50 mg SDV 12 × 50 mg | 71773-0050-12 | Tetraphase Pharmaceuticals | |
| NEW | Oncology | Xermelo® | 10254483 | 250 mg /84 tabs | 70183-0125-84 | TerSera Therapeutics |
| Oncology | Xospata® | 10245498 | 40 mg tab 90 | 00469-1425-90 | Astellas Pharma | |
| Oncology | Xpovio® | 10247829 | 60 mg tab 12 UD bx | 72237-0101-01 | Karyopharm Therapeutics | |
| Oncology | Xpovio® | 10248107 | 80 mg tab 16 UD bx | 72237-0101-02 | Karyopharm Therapeutics | |
| Oncology | Xpovio® | 10244781 | 100 mg tab 20 UD bx | 72237-0101-05 | Karyopharm Therapeutics | |
| Oncology | Xpovio® | 10244744 | 160 mg tab 32 UD bx | 72237-0101-04 | Karyopharm Therapeutics | |
| Oncology | Xtandi® | 10242084 | 40 mg cap 120 | 00469-0125-99 | Astellas Pharma | |
| Oncology | Yervoy® | 10249153 | 50 mg/10 mL | 00003-2327-11 | Bristol Myers Squibb | |
| Oncology | Yervoy® | 10249059 | 200 mg/40 mL | 00003-2328-22 | Bristol Myers Squibb | |
| Oncology | Yondelis® | 10246435 | 1 mg PWD SDV | 59676-0610-01 | Jom Pharmaceutical | |
| Oncology | Yonsa® | 10247137 | 125 mg tabs 120 | 47335-0401-81 | Sun Pharmaceutical Industries Brand | |
| Oncology | Zaltrap® | 10245583 | 100 mg/4 mL SDV SOL | 00024-5840-01 | Genzyme | |
| Oncology | Zaltrap® | 10248515 | 200 mg/8 mL SDV SOL | 00024-5841-01 | Genzyme | |
| Oncology | Zejula® | 10247089 | 100 mg cap 30 | 69656-0103-30 | Glaxosmithkline | |
| Oncology | Zelboraf® | 10244390 | 240 mg/112 tabs | 50242-0090-02 | Genentech | |
| Oncology | Zydelig® | 10246815 | 100 mg/60 tabs | 61958-1701-01 | Gilead | |
| Oncology | Zydelig® | 10247429 | 150 mg/60 tabs | 61958-1702-01 | Gilead | |
| Oncology | Zykadia® | 10248089 | 150 mg/84 tabs | 00078-0694-84 | Novartis | |
| Oncology | Zynlonta™ | 10257760 | 10 mg vial 1 DS | 79952-0110-01 | ADC Therapeutics | |
| Oncology | Zytiga® | 10244663 | 250 mg/120 tabs | 57894-0150-12 | Jom Pharmaceutical |